UNH Stock: Unusual Put Activity Flags Bearish Bet Near Current Price

March 24, 2026

By TrendSpider Editor

UNH Stock: Unusual Put Activity Flags Bearish Bet Near Current Price

A notable options trade hit the tape for UnitedHealth Group Incorporated, with a single put contract drawing attention at a $270 strike expiring in September 2026, carrying a premium of $1,680,000. UNH shares are trading at $270.70, up 0.38% on the session, but remain deeply depressed relative to their 52-week high of $606.345, with the stock sitting far closer to its 52-week low of $234.60. The placement of a sizeable put right at the current trading level suggests at least one large player is positioning for continued downside or hedging meaningful long exposure ahead of the months ahead.

Key Drivers of the UNH Stock Move

Main Catalyst: One unusual put contract was flagged today at a $270 strike expiring September 18, 2026, with a volume of 600 contracts, an open interest utilization of 25%, and a total premium of $1,680,000. The strike is essentially at the money given the current price of $270.70, amplifying the significance of the trade.
Bull Case: The 0.38% gain on the session shows the stock is holding ground near the $270 level, and the put activity could represent hedging from a long holder rather than an outright directional bet against UNH. If the stock stabilizes and recovers, the $270 level could act as a base, with meaningful upside distance to the 52-week high of $606.345.
Bear Case: An at-the-money put with $1,680,000 in premium placed at the current price level is a serious expression of downside concern. With UNH already down dramatically from its 52-week high of $606.345 and trading just $36.10 above its 52-week low of $234.60, the risk skew remains heavily weighted to the downside, and this options flow does nothing to contradict that narrative.

The forward setup for UNH remains challenging. The stock has spent much of the past year under significant pressure, and the concentration of put activity right at the current trading price through September 2026 implies that options participants see limited near-term recovery. The six-month expiration window covers a meaningful stretch of time that includes potential regulatory developments, earnings reports, and ongoing scrutiny of the managed care sector broadly. Any macro or legislative pressure on health insurers could keep the stock pinned near current levels or push it back toward the 52-week low. Traders and investors will want to monitor whether additional put positioning builds around the $270 level in coming sessions, which could confirm a more sustained institutional view on the downside.

UNH Unusual Options Activity

Contract 1: Put | Strike: $270 | Expiry: September 18, 2026 | Volume: 600 | Open Interest Utilization: 25% | Premium: $1,680,000

This is the only unusual contract flagged today, and its positioning directly at the money makes it the most meaningful data point in today's session. A single contract of this premium size is enough to suggest an institutional participant with a defined view on where UNH trades over the next six months.

UNH Seasonality

Late March has historically been a transitional period for managed care stocks as the market begins to look ahead toward second-quarter medical cost trends and forward guidance. With UNH trading near multi-year lows, seasonal patterns that favor sector recovery in spring could be tested if fundamental pressures persist into the coming months.

UNH Relative Performance

UNH's current price of $270.70 represents a decline of more than 55% from its 52-week high of $606.345, an underperformance that stands out sharply relative to broader market benchmarks and most large-cap healthcare peers. While the stock is showing a modest 0.38% gain on the session today, Tuesday, March 24, 2026, that fractional move does little to offset the broader deterioration in price structure. The stock remains in a position where it would need to more than double just to reclaim its prior highs, making it one of the more pronounced laggards in the large-cap healthcare space over the past year.